Abbott Partners With Solvay On Simcor Ahead Of Planned 2008 Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
Solvay will provide sales support in the U.S. in addition to funding development and promotions for the Niaspan/simvastatin combination.
You may also be interested in...
Riding On Humira Sales, Abbott Aims For Dominance In Lipid Management Market
Product launches and Humira label expansions will compensate for Depakote generics entering the market in July, CEO White says.
Riding On Humira Sales, Abbott Aims For Dominance In Lipid Management Market
Product launches and Humira label expansions will compensate for Depakote generics entering the market in July, CEO White says.
Abbott’s Simcor Significantly Lowers Non-HDL Cholesterol In SEACOAST Phase III Study
Simcor, with a Feb. 20 user fee date, could face competition from two Merck investigational extended-release niacin combinations, including Cordaptive (laropiprant), with an anticipated FDA action date in Q2 2008.